Insider Transactions Reported by 18 Insiders of Cyclerion Therapeutics, Inc.

Symbol
CYCN on Nasdaq
Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 06 Jan 2025

Cyclerion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter M. Hecht Director, 10%+ Owner $1,538,006 25 Mar 2025
Regina M. Graul President and Chief Executive Officer, Director $340,529 05 Aug 2024
MCGUIRE TERRANCE Director $142,624 30 Nov 2023
ERROL B. DESOUZA Director $101,850 30 Nov 2023
Michael J. Higgins Director $84,535 25 Mar 2025
Steven Hyman Director $67,900 30 Nov 2023
Dina Katabi Director $67,900 30 Nov 2023
Slate Path Capital LP 10%+ Owner $0 21 Nov 2024
RHONDA CHICKO Chief Financial Officer 07 Aug 2025
Andreas Busch Chief Scientific Officer 20 Jan 2022
Kevin Churchwell Director 24 Jun 2021
Ole Isacson Director 14 Jun 2022
Cheryl Gault Chief Operating Officer 20 Jan 2022
GEORGE H. CONRADES Director 14 Jun 2022
Stephanie Lovell Director 14 Jun 2022
Michael Mendelsohn Director 14 Jun 2022
Anjeza Gjino Chief Financial Officer 20 Jan 2022
Marsha Fanucci Director 14 Jun 2022

Recent Insider Transactions by Companies or Individuals for Cyclerion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.